Literature DB >> 32892277

A Genome-Wide Study of Single-Nucleotide Polymorphisms in MicroRNAs and Further In Silico Analysis Reveals Their Putative Role in Susceptibility to Late-Onset Alzheimer's Disease.

Soraya Herrera-Espejo1, Borja Santos-Zorrozua1, Paula Alvarez-Gonzalez1, Idoia Martin-Guerrero1,2, Marian M de Pancorbo3, Africa Garcia-Orad1,2, Elixabet Lopez-Lopez4,5.   

Abstract

Late-onset Alzheimer's disease (LOAD) is a neurodegenerative disorder of growing relevance in an aging society for which predictive biomarkers are needed. Many genes involved in LOAD are tightly controlled by microRNAs (miRNAs), which can be modulated by single-nucleotide polymorphisms (SNPs). Our aim was to determine the association between SNPs in miRNAs and LOAD. We selected all SNPs in pre-miRNAs with a minor allele frequency (MAF) > 1% and genotyped them in a cohort of 229 individuals diagnosed with LOAD and 237 unrelated healthy controls. In silico analyses were performed to predict the effect of SNPs on miRNA stability and detect downstream pathways. Four SNPs were associated with LOAD risk with a p value < 0.01 (rs74704964 in hsa-miR-518d, rs71363366 in hsa-miR-1283-2, rs11983381 in hsa-miR-4653, and rs10934682 in hsa-miR-544b). In silico analyses support a possible functional effect of those SNPs in miRNA levels and in the regulation of pathways of relevance for the development of LOAD. Although the results are promising, additional studies are needed to validate the association between SNPs in miRNAs and the risk of developing LOAD. Graphical abstract.

Entities:  

Keywords:  Late-onset Alzheimer’s disease; MicroRNAs; Single nucleotide polymorphisms; Susceptibility

Mesh:

Substances:

Year:  2020        PMID: 32892277     DOI: 10.1007/s12035-020-02103-0

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  54 in total

Review 1.  Early- and late-onset Alzheimer disease: Are they the same entity?

Authors:  P Tellechea; N Pujol; P Esteve-Belloch; B Echeveste; M R García-Eulate; J Arbizu; M Riverol
Journal:  Neurologia (Engl Ed)       Date:  2015-11-03

Review 2.  Alzheimer's Disease and ncRNAs.

Authors:  Rotem Maoz; Benjamin P Garfinkel; Hermona Soreq
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 3.  Biomarkers for the Early Detection and Progression of Alzheimer's Disease.

Authors:  Scott E Counts; Milos D Ikonomovic; Natosha Mercado; Irving E Vega; Elliott J Mufson
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

4.  Altered gene expression in late-onset Alzheimer's disease due to SNPs within 3'UTR microRNA response elements.

Authors:  Jyoti Roy; Bibekanand Mallick
Journal:  Genomics       Date:  2017-03-09       Impact factor: 5.736

5.  Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment.

Authors:  E J Mufson; E Y Chen; E J Cochran; L A Beckett; D A Bennett; J H Kordower
Journal:  Exp Neurol       Date:  1999-08       Impact factor: 5.330

6.  Neuropathologic substrate of mild cognitive impairment.

Authors:  William R Markesbery; Frederick A Schmitt; Richard J Kryscio; Daron G Davis; Charles D Smith; David R Wekstein
Journal:  Arch Neurol       Date:  2006-01

7.  Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.

Authors:  D A Bennett; J A Schneider; J L Bienias; D A Evans; R S Wilson
Journal:  Neurology       Date:  2005-03-08       Impact factor: 9.910

Review 8.  Alzheimer's disease: presence and role of microRNAs.

Authors:  Manasa Basavaraju; Alexandre de Lencastre
Journal:  Biomol Concepts       Date:  2016-08-01

Review 9.  Genetic markers for diagnosis and pathogenesis of Alzheimer's disease.

Authors:  Dong Hee Kim; Seung Hyeon Yeo; Jeong-Min Park; Ji Ye Choi; Tae-Hee Lee; Soon Yong Park; Mee Sun Ock; Jungwoo Eo; Heui-Soo Kim; Hee-Jae Cha
Journal:  Gene       Date:  2014-05-15       Impact factor: 3.688

10.  A functional polymorphism in the promoter region of microRNA-146a is associated with the risk of Alzheimer disease and the rate of cognitive decline in patients.

Authors:  Lili Cui; You Li; Guoda Ma; Yan Wang; Yujie Cai; Shengyuan Liu; Yanyan Chen; Jia Li; Yuliu Xie; Gen Liu; Bin Zhao; Keshen Li
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

View more
  4 in total

1.  Identification of miRNA-Target Gene Pairs in the Parietal and Frontal Lobes of the Brain in Patients with Alzheimer's Disease Using Bioinformatic Analyses.

Authors:  Jiao Li; Chunli Xu; Junfang Zhang; Caixia Jin; Xiujuan Shi; Chen Zhang; Song Jia; Jie Xu; Xin Gui; Libo Xing; Lixia Lu; Lei Xu
Journal:  Neurochem Res       Date:  2021-02-13       Impact factor: 3.996

Review 2.  The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives.

Authors:  Hannah Walgrave; Lujia Zhou; Bart De Strooper; Evgenia Salta
Journal:  Mol Neurodegener       Date:  2021-11-06       Impact factor: 14.195

3.  Association of rs2910164 in miR-146a with type 2 diabetes mellitus: A case-control and meta-analysis study.

Authors:  Wei-Wei Chang; Li-Ying Wen; Liu Zhang; Xin Tong; Yue-Long Jin; Gui-Mei Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-27       Impact factor: 6.055

Review 4.  Interplay of RNA-Binding Proteins and microRNAs in Neurodegenerative Diseases.

Authors:  Chisato Kinoshita; Noriko Kubota; Koji Aoyama
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.